Microbiology: Current Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Microbiology: Current Research (2024) Volume 8, Issue 1

CRISPR-based genome engineering in microbial biotechnology: Advances and applications.

Corrie Davis *

Department of Microbial Biotechnology, Peking University, China

*Corresponding Author:
Corrie Davis
Department of Microbial Biotechnology, Peking University, China
E-mail: davis.c@pku.edu.cn

Received: 01-Feb-2024, Manuscript No. AAMCR-24-135072; Editor assigned: 02-Feb-2024, PreQC No AAMCR-24-135072 (PQ) Reviewed:16-Feb-2024, QC No. AAMCR-24-135072 Revised:23-Feb-2024, Manuscript No. AAMCR-24-135072 (R); Published:28-Feb-2024, DOI:10.35841/aamcr-8.1.193

Citation: Davis C. CRISPR-based genome engineering in microbial biotechnology: Advances and applications. J Micro Curr Res. 2024; 8(1):193

Visit for more related articles at Microbiology: Current Research

Introduction

Genome editing technologies have revolutionized the field of biotechnology, enabling scientists to precisely manipulate genetic material with unprecedented accuracy and efficiency. Among these techniques, CRISPR-Cas9 has emerged as a game-changer, offering a versatile toolkit for targeted genome modifications. In microbial biotechnology, CRISPR-based genome engineering holds immense promise, facilitating the development of novel strains with tailored functionalities for various industrial applications [1].

At the heart of CRISPR-Cas9 technology lies its ability to precisely target specific DNA sequences and induce modifications with remarkable precision. Unlike traditional genetic engineering methods, CRISPR-Cas9 allows researchers to edit genomes with greater speed, efficiency, and accuracy, making it an invaluable tool for microbial biotechnologists. By harnessing this technology, scientists can engineer microbial strains with desired traits such as enhanced productivity, improved metabolite production, and increased tolerance to environmental stresses [2].

One of the key advantages of CRISPR-based genome engineering in microbial biotechnology is its versatility. Researchers can use CRISPR-Cas9 to introduce targeted genetic modifications, including gene knockouts, knock-ins, and precise nucleotide substitutions, enabling the fine-tuning of metabolic pathways and the optimization of microbial hosts for specific bioproduction processes. This flexibility has opened up new avenues for the development of microbial cell factories for the sustainable production of biofuels, pharmaceuticals, specialty chemicals, and other valuable product [3].

In addition to its role in strain engineering, CRISPR technology has also facilitated the study of microbial biology and the elucidation of complex genetic regulatory networks. By employing CRISPR-based tools such as CRISPRi (CRISPR interference) and CRISPRa (CRISPR activation), researchers can modulate gene expression levels with high precision, enabling the systematic interrogation of gene function and the characterization of metabolic pathways in microbial systems [4].

Furthermore, CRISPR-based genome editing has revolutionized the field of synthetic biology, enabling the design and construction of synthetic genetic circuits and biosensors in microbial hosts. These engineered systems can be used for a wide range of applications, including biosensing, bioremediation, and the production of value-added compounds. CRISPR-based biosensors, for example, can be designed to detect specific environmental pollutants or biomolecules, offering a rapid and cost-effective means of monitoring environmental quality or diagnosing diseases [5, 6].

Another area where CRISPR technology is making significant strides is in the development of microbial therapies for human health. CRISPR-based genome editing has the potential to revolutionize the treatment of infectious diseases by enabling the engineering of probiotic microbes that can target and eliminate pathogenic bacteria in the gut. Moreover, CRISPR-based approaches hold promise for the development of next-generation antimicrobials and vaccines, offering new strategies for combating antibiotic-resistant pathogens and emerging infectious diseases [7,8].

Despite its tremendous potential, CRISPR-based genome engineering also poses challenges and ethical considerations that must be addressed. Off-target effects, unintended mutations, and the potential for horizontal gene transfer are among the key concerns associated with CRISPR technology. Moreover, questions surrounding the equitable distribution of CRISPR-based therapies and the potential misuse of genome editing techniques raise important ethical and regulatory issues that require careful consideration [9, 10].

Conclusion

CRISPR-based genome engineering represents a powerful tool for advancing microbial biotechnology and driving innovation in various fields ranging from industrial biomanufacturing to healthcare. By enabling precise and efficient manipulation of microbial genomes, CRISPR technology is accelerating the development of sustainable bioprocesses, novel therapeutics, and innovative solutions to pressing global challenges. However, it is essential to proceed with caution and adhere to ethical principles to ensure the responsible and equitable use of this transformative technology for the benefit of society.

References

  1. Wang Z, Zuo J, Gong J, et al. Development of a multiplex PCR assay for the simultaneous and rapid detection of six pathogenic bacteria in poultry. Amb Express. 2019 ;9(1):1-1.

    2. Indexed at, Google Scholar, Cross Ref

  2. Chamberlain JS, Gibbs RA, Rainer JE, et al. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988;16(23):11141-56

    3. Indexed at, Google Scholar, Cross Ref

  3. Abavisani M, Khayami R, Hoseinzadeh M, et al. CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance. Drug Resist Updat. 2023:100948.

    4. Indexed at, Google Scholar, Cross Ref

  4. Zhang T, Zhou W, Lin X, et al. Light-up RNA aptamer signaling-CRISPR-Cas13a-based mix-and-read assays for profiling viable pathogenic bacteria. Biosens Bioelectron. 2021;176:112906.

    5. Indexed at, Google Scholar, Cross Ref

  5. Ke X, Ou Y, Lin Y, et al. Enhanced chemiluminescence imaging sensor for ultrasensitive detection of nucleic acids based on HCR-CRISPR/Cas12a. Biosens Bioelectron. 2022;212:114428.

    6. Indexed at, Google Scholar, Cross Ref

  6. Kelleher RJ, Govindarajan A, Tonegawa S. Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron. 2004;44(1):59-73.

    7. Indexed at, Google Scholar

  7. Yap EL, Greenberg ME. Activity-regulated transcription: bridging the gap between neural activity and behavior. Neuron. 2018;100(2):330-48.

    8. Indexed at, Google Scholar, Cross Ref

  8. Sydow JF, Cramer P. RNA polymerase fidelity and transcriptional proofreading. Curr Opin Struct Biol. 2009;19(6):732-9.

    9. Indexed at, Google Scholar, Cross Ref

  9. Ma C, Mobli M, Yang X, et al. RNA polymerase-induced remodelling of NusA produces a pause enhancement complex. Nucleic acids Res. 2015;43(5):2829-40.

    10. Indexed at, Google Scholar, Cross Ref

  10. Wells SE, Hillner PE, Vale RD, et al. Circularization of mRNA by eukaryotic translation initiation factors. Mol Cell. 1998;2(1):135-40.

    11. Indexed at, Google Scholar

Get the App